In Brief


Clinical Roundup
Drugs & Targets
NCI Trials


NCI Trials for Nov. 2021
The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.For further information, contact the principal investigator listed.
Trending Stories
- Right-wing provocateur Laura Loomer comes for FDA’s Vinay Prasad
- FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts
- Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER director
His appointment came out of “proximity” to Makary and Bhattacharya - U.S. News & World Report expands evaluation of outcomes in cancer subspecialties
- Robert Winn: If Medicaid gets massive cuts or goes away, where will these patients get care?
- Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out